Answers are grounded in this paper and cite their sources.
FDA and NIH unveil initiatives to advance animal alternatives in research, indicating significant funding and guidance efforts.
The FDA and NIH have announced new steps to reduce animal use in research. The FDA provided the first guidance for evaluating non-animal alternatives, or new approach methodologies (NAM), for drug pharmacology and toxicology. The NIH is providing more than $150 million for new centers and projects to develop and implement additional NAMs. But cancer researchers say that alternative approaches aren't ready to replace animal models.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: